HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Cardiovascular Disease

 

The Practical Cardiology™ Cardiovascular Disease clinical resource center hosts content related to a wide array of cardiovascular conditions. The leading cause of death in the United States, the term cardiovascular disease encompasses a multitude of conditions and this page serves as a hub for information to several of the most common conditions, including atherosclerotic cardiovascular disease, acute coronary syndromes, hypertension, and more.

FDA Warns 7 Companies Over Illegal Claims of Cardiovascular Benefits from Supplements

November 18, 2022

Announced in a statement on November 17, the US FDA issued letters to 7 companies related to unsupported claims of supplements being able to cure, treat, mitigate or prevent cardiovascular disease or related conditions, such as atherosclerosis, stroke or heart failure, in violation of the Federal Food, Drug, and Cosmetic Act.

Subcutaneous ICD Could Reduce Lead-Related Complications By More than 90%

November 14, 2022

Data from the ATLAS trial indicate use of a subcutaneous ICD was associated with a 92% reduction in lead-related complications compared to TV-ICD without compromising the effectiveness of shocks, but investigators express caution over an increased incidence of inappropriate shocks with the S-ICD.

CDC-Led Report Suggests 5-10 Years of Progress Against Cardiovascular Disease Erased During COVID-19 Pandemic

October 31, 2022

An analysis of trends in cardiovascular disease-related mortality from the US CDC WONDER database provides new insight into the apparent increases in mortality from cardiovascular disease observed during 2020 relative to the decreases in rate seen from 2010-2019.

Cardiology Month in Review: October 2022

October 29, 2022

The October 2022 cardiology month in review features the top content from HFSA 2022, new data related to antithrombotic therapy in atrial fibrillation, and shining a spotlight on the AHA’s scientific statement on patient-reported outcomes in peripheral artery disease.